To: | Streamline Medical Group Naples, LLC (fcampoamor@holmesfraser.com) |
Subject: | U.S. Trademark Application Serial No. 88283151 - 10X LEAN - 88283151 |
Sent: | October 15, 2019 02:15:35 PM |
Sent As: | ecom120@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88283151
Mark: 10X LEAN
|
|
Correspondence Address: 711 5th Avenue South, Suite 200
|
|
Applicant: Streamline Medical Group Naples, LLC
|
|
Reference/Docket No. 88283151
Correspondence Email Address: |
|
The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS) and/or Electronic System for Trademark Trials and Appeals (ESTTA). A link to the appropriate TEAS response form and/or to ESTTA for an appeal appears at the end of this Office action.
Issue date: October 15, 2019
Introduction
This Office action is in response to applicant’s communication filed on October 11, 2019.
In a previous Office action dated April 12, 2019, the trademark examining attorney refused registration of the applied-for mark based on Trademark Act Sections 1 and 45 for failure to show the applied-for mark in use in commerce with any of the specified goods. In addition, applicant was required to provide information about the specimen.
The requirement to provide additional information has been obviated. See TMEP §§715.03(a)(ii)(B), 715.04(a).
The trademark examining attorney maintains and now makes FINAL the Sections 1 and 45 refusal. See 37 C.F.R. §2.63(b); TMEP §714.04.
Specimen Refused
Applicant was previously refused registration in International Class 5 because the original specimen appeared to consist of a digitally altered image or a mock-up of the intended depiction of the mark on the goods or their packaging for future use in commerce. An application based on Trademark Act Section 1(a) must include a specimen showing the applied-for mark in use in commerce for each international class of goods identified in the application or amendment to allege use. 15 U.S.C. §1051(a)(1); 37 C.F.R. §§2.34(a)(1)(iv), 2.56(a); TMEP §§904, 904.07(a).
In response to the refused international class, applicant conceded that the specimen was created for submission with this application. Specifically, applicant stated that the specimen was generated so as to preclude proteted patient health information that normally included on the labeling of applicant’s goods. Further, applicant argued that the specimen of record is acceptable because applicant cannot lawfully provide a specimen showing actual use of the applied-for mark in commerce because a specimen which shows actual use of the mark in association with the applicant’s goods would comprise protected patient health information.
If, for a valid reason, the applicant does not want certain information to become part of a public record, the applicant should consider options such as redacting confidential portions of documents prior to their submission. TMEP §404. However, merely stating that a specimen showing actual use of the applied-for mark in commerce cannot be provided because the applicant’s labels contain protected patient health information does not obviate the requirement to provide a specimen showing the mark in use in commerce with the identified goods. Thus, applicant’s argument that the specimen of record is acceptable is unpersuasive.
Actual “use in commerce” occurs when the mark is placed on the goods or their containers in the ordinary course of trade and the goods are actually sold or transported, and not merely to reserve a right in the mark. See 15 U.S.C. §1127; TMEP §901.01.
A digitally altered image, mock-up, or photograph of an intended depiction of a mark on a label, tag, or piece of paper placed on top of an applicant’s or a third party’s goods or packaging merely for the purposes of filing a trademark application is generally not acceptable to show applicant’s use of the applied-for mark in commerce. See 15 U.S.C. §1127; TMEP §§904.03(a), 904.04(a), 904.07(a); cf. In re Chica, Inc., 84 USPQ2d 1845, 1848 (TTAB 2007); In re The Signal Cos., 228 USPQ 956, 957-58 n.4 (TTAB 1986). Applicant must show the mark used on applicant’s goods or packaging as it is seen by the purchasing public, with goods that are sold or transported in commerce that is regulated by the U.S. Congress. See 15 U.S.C. §1127; TMEP §901.01.
Applicant may respond to this final refusal by satisfying one of the following for each applicable international class:
(1) Submit a different specimen (a verified “substitute” specimen) that (a) was in actual use in commerce at least as early as the filing date of the application or prior to the filing of an amendment to allege use and (b) shows the mark in actual use in commerce for the goods identified in the application or amendment to allege use. A “verified substitute specimen” is a specimen that is accompanied by the following statement made in a signed affidavit or supported by a declaration under 37 C.F.R. §2.20: “The substitute (or new, or originally submitted, if appropriate) specimen(s) was/were in use in commerce at least as early as the filing date of the application or prior to the filing of the amendment to allege use.” The substitute specimen cannot be accepted without this statement.
(2) Amend the filing basis to intent to use under Section 1(b), for which no specimen is required. This option will later necessitate additional fee(s) and the filing of an acceptable specimen when actual use of the mark in the sale or transport of goods occurs.
For an overview of both response options referenced above and instructions on how to satisfy either option online using the Trademark Electronic Application System (TEAS) form, please go to the Specimen webpage.
Conclusion
Please call or email the assigned trademark examining attorney with questions about this Office action. Although the trademark examining attorney cannot provide legal advice or statements about applicant’s rights, the trademark examining attorney can provide applicant with additional explanation about the refusal in this Office action. See TMEP §§705.02, 709.06. Although the USPTO does not accept emails as responses to Office actions, emails can be used for informal communications and will be included in the application record. See 37 C.F.R. §§2.62(c), 2.191; TMEP §§304.01-.02, 709.04-.05.
TEAS PLUS OR TEAS REDUCED FEE (TEAS RF) APPLICANTS – TO MAINTAIN LOWER FEE, ADDITIONAL REQUIREMENTS MUST BE MET, INCLUDING SUBMITTING DOCUMENTS ONLINE: Applicants who filed their application online using the lower-fee TEAS Plus or TEAS RF application form must (1) file certain documents online using TEAS, including responses to Office actions (see TMEP §§819.02(b), 820.02(b) for a complete list of these documents); (2) maintain a valid e-mail correspondence address; and (3) agree to receive correspondence from the USPTO by e-mail throughout the prosecution of the application. See 37 C.F.R. §§2.22(b), 2.23(b); TMEP §§819, 820. TEAS Plus or TEAS RF applicants who do not meet these requirements must submit an additional processing fee of $125 per class of goods. 37 C.F.R. §§2.6(a)(1)(v), 2.22(c), 2.23(c); TMEP §§819.04, 820.04. However, in certain situations, TEAS Plus or TEAS RF applicants may respond to an Office action by authorizing an examiner’s amendment by telephone or e-mail without incurring this additional fee.
How to respond. Click to file a response to this final Office action and/or appeal it to the Trademark Trial and Appeal Board (TTAB)
/Joshua S. Toy/
Trademark Examining Attorney
Law Office 120
571-272-4856
joshua.toy@uspto.gov
RESPONSE GUIDANCE